These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9345444)
1. Recent advances in the pharmacological control of experimental allergic encephalomyelitis (EAE) and the implications for multiple sclerosis treatment. Bolton C Mult Scler; 1995 Nov; 1(3):143-9. PubMed ID: 9345444 [TBL] [Abstract][Full Text] [Related]
2. The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis. Bolton C Inflammopharmacology; 2007 Oct; 15(5):183-7. PubMed ID: 17943249 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS). Schorlemmer HU; Seiler FR Drugs Exp Clin Res; 1991; 17(10-11):461-9. PubMed ID: 1841035 [TBL] [Abstract][Full Text] [Related]
4. 15-Deoxyspergualin (15-DOS) for therapy in an animal model of multiple sclerosis (MS): disease modifying activity on acute and chronic relapsing experimental allergic encephalomyelitis (EAE). Schorlemmer HU; Seiler FR Agents Actions; 1991 Sep; 34(1-2):156-60. PubMed ID: 1793022 [TBL] [Abstract][Full Text] [Related]
5. Combined Treatment with Zinc Aspartate and Intravenous Immunoglobulins (IVIGs) Ameliorates Experimental Autoimmune Encephalomyelitis (EAE). Straubel D; Thielitz A; Reinhold A; Grüngreiff K; Reinhold D J Immunol Res; 2018; 2018():5982169. PubMed ID: 30356433 [TBL] [Abstract][Full Text] [Related]
6. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis. Stuerzebecher S; Martin R Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717 [TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods. Khan N; Woodruff TM; Smith MT Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977 [TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis. Zhu Z; You W; Xie Z; Wang P; Liu Z; Wang C; Bi J J Int Med Res; 2014 Apr; 42(2):530-41. PubMed ID: 24496150 [TBL] [Abstract][Full Text] [Related]
9. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice. Bing SJ; Ha D; Hwang I; Park E; Ahn G; Song JY; Jee Y Am J Chin Med; 2016; 44(6):1099-1110. PubMed ID: 27627913 [TBL] [Abstract][Full Text] [Related]
10. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Steinman L; Zamvil SS Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891 [TBL] [Abstract][Full Text] [Related]
11. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Sriram S; Steiner I Ann Neurol; 2005 Dec; 58(6):939-45. PubMed ID: 16315280 [TBL] [Abstract][Full Text] [Related]
12. Are current disease-modifying therapeutics in multiple sclerosis justified on the basis of studies in experimental autoimmune encephalomyelitis? Farooqi N; Gran B; Constantinescu CS J Neurochem; 2010 Nov; 115(4):829-44. PubMed ID: 20807309 [TBL] [Abstract][Full Text] [Related]
13. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy. Mondal S; Pahan K PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428 [TBL] [Abstract][Full Text] [Related]
14. Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells. Donia M; Mangano K; Amoroso A; Mazzarino MC; Imbesi R; Castrogiovanni P; Coco M; Meroni P; Nicoletti F J Autoimmun; 2009 Sep; 33(2):135-40. PubMed ID: 19625166 [TBL] [Abstract][Full Text] [Related]
15. Glutamate receptors in neuroinflammatory demyelinating disease. Bolton C; Paul C Mediators Inflamm; 2006; 2006(2):93684. PubMed ID: 16883070 [TBL] [Abstract][Full Text] [Related]
16. The mechanism of sesame oil in ameliorating experimental autoimmune encephalomyelitis in C57BL/6 mice. Ghazavi A; Mosayebi G Phytother Res; 2012 Jan; 26(1):34-8. PubMed ID: 21538630 [TBL] [Abstract][Full Text] [Related]
17. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells. Hwang I; Ahn G; Park E; Ha D; Song JY; Jee Y Immunol Lett; 2011 Aug; 138(2):169-78. PubMed ID: 21524666 [TBL] [Abstract][Full Text] [Related]
18. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review. Aharoni R J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599 [TBL] [Abstract][Full Text] [Related]
19. Effects of imatinib mesylate in mouse models of multiple sclerosis and in vitro determinants. Azizi G; Haidari MR; Khorramizadeh M; Naddafi F; Sadria R; Javanbakht MH; Sedaghat R; Tofighi Zavareh F; Mirshafiey A Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):198-206. PubMed ID: 24659124 [TBL] [Abstract][Full Text] [Related]